Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

tools 20 accc-cancer.org | March–April 2017 | OI Approved Drugs • Egalet Corporation (egalet.com) announced that the U.S. Food and Drug Administration (FDA) has approved Arymo™ ER (morphine sulfate) extended- release (ER) tablets C-II for the manage- ment of pain severe enough to require daily, around-the-clock, long-term opioid treat- ment and for which alternative treatment …
Nearly 13 years ago, I slipped through a significant and potentially fatal crack in our healthcare system when I was diagnosed with advanced stage breast cancer.
14 accc-cancer.org | Vol. 36, No. 3, 2021 | OI Approved Drugs • On Feb. 12, G1 Therapeutics, Inc. (g1therapeutics.com) announced that the U.S. Food and Drug Administration (FDA) approved Cosela™ (trilaciclib) to decrease the incidence of chemotherapy- induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing …
SO03-Providing-Real-Time-Access-to-Patient-Records
MA10-Action
Chemotherapy Review: Focus on Ordering and Administration Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Chemotherapy Review: Focus on Ordering and Administration Natasha Leskovsek …
New Products Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 New Products To cite this article: (2000) New Products, Oncology Issues, 15:2, 16-17, DOI: 10.1080/10463356.2000.11905115 …
Evaluating Quality of Care: ACCC's Clinical Indicator Project EVALUATING QUALITY OF CARE: ACCC'S CLINICAL INDICATOR PROJECT ACCC CLINICAL INDICATOR CORE COMMITTEE Charles Coltrnan, M.D.• Southwest Oncology Group. San Antonio. TX William Creasman. M.D.• Medical University of South Carolina. Charleston, SC Peter Deckers. M.D., National Surgical Adjuvant Breast & Bowel Project. Avon. CT Herbert …
tools Approved Drugs • On June 27, the U.S. Food and Drug Administration (FDA) approved Darzalex® (daratumumab) (Janssen Biotech, Inc., Janssen.com) in combina- tion with lenalidomide and dexametha- sone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. • On June 14, Amgen (amgen.com) and Allergan …
JF05-Tools
Kettering Medical Center Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Kettering Medical Center A History of Innovation: A PET Program To cite this article: (1999) Kettering Medical …
Practice Management: Coping with 1990 Coding Revisions Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Practice Management: Coping with 1990 Coding Revisions Cavan Redmond To cite …
MA03-6-Questions-to-Answer-BEFORE-You-Build-a-New-Cancer-Center
Cancer Care Benefits Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Cancer Care Benefits Albert B. Einstein Jr. To cite this article: Albert B. Einstein Jr. (1994) Cancer Care …
issues Another Wild Ride? BY LEAH RALPH Congress rang in the New Year with a massive tax overhaul and a government shutdown over immigration—another unpredictable year in Washington, D.C., seems like a foregone conclusion. Now several months into 2018, is the turbulence slowing down or ratcheting up? Although MedPAC’s January vote recom- mended that Congress eliminate the Merit-Based Incentive …
Safe Harbors for Fee Reductions Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Safe Harbors for Fee Reductions John S. Hoff To cite this article: John S. Hoff (1996) Safe Harbors …
MJ09-Meet-ACCCs-New-President-Luana-R.-Lamkin-RN-MPH
Coding and Documentation for 3-Dimensional Simulation, 77295 Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Coding and Documentation for 3-Dimensional Simulation, 77295 Carl R. Bogardus …
Hospital Reimbursement, Charges, and Profit and Loss for Cancer and Cancer-Related DRGs HOSPITAL REIMBURSEMENT, CHARGES, AND PROFIT AND LOSS FOR CANCER AND CANCER-RELATED DRGs John L. Young, Jr., DrPH Lee E. Mortenson, MS, MPA Michael S. Ney, MPA John L. Young, Jr., DrPH, is vice president, epidemiology and research, ELMServices, Inc., Lee E. Mortenson, MS, MPA, is exec- utive …
JA02-President